VYNE

Vyne Therapeutics Inc$0.66 1.35%
Health CareUSCUSIP 92941V308· EOD Jun 5, 2026◍ Confluence graph
Tracked 13F Holders
8
+3 QoQ
13F Value (tracked)
$2.2M
Insider Net · 180d
$0
0↑ 0↓
Recent Filings
15
Smart-money sentimentBullish
BearishBullish
13F funds (latest Q)4 adding · 0 trimming
Insider net (180d)$0

Price & smart-money activity

$0.66 1.35%5Y -99.0%
$0.28$18.38$36.48$54.58$72.68202120222023202420252026528433346474873125782
Hover for who · click for detailEnd-of-day closing prices52w $0.29 – $1.77
Build

Use VYNE data in an agent

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Build

Ask your agent who owns VYNE

This stock page is the Follow view. The Build view lets your agent query VYNE owners, fund changes, insider filings, and source links through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/VYNE"
Ask your agent
Use Arkolith to show who owns VYNE,
which funds added or reduced it, and which
SEC filings prove each claim.

Top institutional holders

8 tracked 13F filers
#FundPosition valueSharesLast moveAs ofHistory
1Nantahala Capital Management, LLC
$1.2M
2.0M
+100%
Added · +1.0M sh
Q1 2026
2BRAIDWELL LP
$547K
916K
New
+916K sh
Q1 2026
3CITADEL ADVISORS LLC
$307K
514K
17×
Added · +484K sh
Q1 2026
4VANGUARD FIDUCIARY TRUST CO
$110K
183K
New
+183K sh
Q1 2026
5BOOTHBAY FUND MANAGEMENT, LLC
$49K
81K
Held
Q1 2026
6STATE STREET CORP
$9K
16K
Held
Q1 2026
7CWM, LLC
$299
500
Held
Q1 2026
8Larson Financial Group LLC
$1
2
New
+2 sh
Q1 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Fund activity: latest quarter

Opened (NEW)
2
funds
Added
2
funds
Reduced
0
funds
Exited
0
funds

Insider activity (Form 4)

Full insider page →
Buys · 180d
$0
0 insiders
Sells · 180d
$0
0 insiders
Net
$0
0 P/S txns
Signal
Mixed
open-market
DateInsiderRoleActionSharesValue
Dec 31, 2025Harsch MutyaCHIEF LEGAL OFFICER AND GCTax withholding (F)4K$2K
Dec 31, 2025Zeronda TylerCHIEF FINANCIAL OFFICERTax withholding (F)8K$5K
Dec 31, 2025Stuart IainCHIEF SCIENTIFIC OFFICERTax withholding (F)2K$1K
Dec 31, 2025Domzalski DavidPRESIDENT AND CEO, DirectorTax withholding (F)13K$7K
Dec 12, 2025LEPORE PATRICK GDirectorGrant (A)20K$0
Dec 12, 2025BARBARI SHARONDirectorGrant (A)20K$0
Dec 12, 2025Basta Steven LDirectorGrant (A)20K$0
Dec 12, 2025Little Elisabeth SandovalDirectorGrant (A)20K$0
Sep 30, 2025Zeronda TylerCHIEF FINANCIAL OFFICERTax withholding (F)3K$1K
Sep 30, 2025Stuart IainCHIEF SCIENTIFIC OFFICERTax withholding (F)2K$834
Sep 30, 2025Domzalski DavidPRESIDENT AND CEO, DirectorTax withholding (F)13K$4K
Sep 30, 2025Harsch MutyaCHIEF LEGAL OFFICER AND GCTax withholding (F)4K$1K

Institutional ownership over time

30 funds+13 since Q1 2023
01632Q1 2023Q4 2023Q3 2024Q2 2025Q1 2026
funds holding aggregate valuelatest $4.7M

Funds that own VYNE also own

CompanyCo-held byCombined value
ESTABLISHMENT LABS HOLDINGSESTA6 funds$118.1M
SOLENO THERAPEUTICS INCSLNOEUR6 funds$107.6M
REVOLUTION MEDICINES INCRVMD6 funds$94.8M
FULCRUM THERAPEUTICS INCFULC6 funds$59.8M
EVOLUS INCEOLS6 funds$41.8M
THERMO FISHER SCIENTIFIC INCTMO5 funds$489.8M
ELEVANCE HEALTH INCELV5 funds$478.3M
CVS HEALTH CORPCVS5 funds$423.9M
BOSTON SCIENTIFIC CORPBSX5 funds$306.7M
BIOMARIN PHARMACEUTICAL INCBMRN5 funds$294.0M
XENON PHARMACEUTICALS INCXENE5 funds$247.9M
DANAHER CORPDHR5 funds$246.4M

Ranked by how many of VYNE's institutional holders also hold each name, a cross-fund conviction signal. Via the MCP server (ticker.co_held).

Recent filings

15 shown

Browse more

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for VYNE. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes. Every panel above is one call to the Arkolith API & MCP server.